MPP+-induced neurotoxicity in mouse is age-dependent: Evidenced by the selective inhibition of complexes of electron transport

Brain Research

Volumn 715, Issue 1-2, 1996, Pages 1-8

  Desai, Varsha G ^a   Feuers, Ritchie J ^a,b   Hart, Ronald W ^a   Ali, Syed F ^a,b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

1 methyl 4 phenyl 1,2,3,6 tetrahydropyridine (MPTP); 1 methyl 4 phenylpyridine (MPP+); cytochrome c oxidase; NADH ubiquinone oxidoreductase; neurotoxicity; succinate ubiquinone oxidoreductase; ubiquinol cytochrome c reductase

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ADENOSINE TRIPHOSPHATE; CYTOCHROME C OXIDASE; GLUTATHIONE; OXIDOREDUCTASE;

ADOLESCENT; AGED; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; ELECTRON TRANSPORT; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RESPIRATORY CHAIN;

EID: 0029964357     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(95)01255-9     Document Type: Article

References (60)

1. Adams, J.D. and Odunze, I.N., Oxygen free radicals and Parkinson's disease, Free Radic. Biol. Med., 10 (1991) 161-169.
2. + induced oxygen radical formation with mitochondrial enzymes, Free Radic. Biol. Med., 15 (1993) 181-186.
3. Ali, S.F., David, S.N. and Newport, G.D., Age-related susceptibility to MPTP-induced neurotoxicity in mice, Neurotoxicology, 14 (1993) 29-34.
4. Ali, S.F., David, S.N., Newport, G.D., Cadet, J.L. and Slikker, W. Jr., MPTP-induced oxidative stress and neurotoxicity are age-dependent: evidence from measures of reactive oxygen species and striatal dopamine levels, Synapse, 18 (1994) 27-34.
5. Attardi, G., Organization and expression of the mammalian mitochondrial genome: a lesion in economy, Trends Biochem. Sci., 6 (1981) 100-103.
6. Bates, T.E., Heales, S.J.R., Davies, S.E.C., Boakye, P. and Clark, J.B., Effects of 1-methyl-4-phenylpyridine on isolated rat brain mitochondria: evidence for the primary involvement of energy depletion, J. Neurochem., 63 (1994) 640-648.
7. Boffoli, D., Scacco, S.C., Vergari, R., Salarino, G., Santacroce, G. and Papa, S., Decline with age of the respiratory chain activity in human skeletal muscle, Biochem. Biophys. Acta, 1226 (1994) 73-82.
8. Boudizi, M.F., Schagger, H., Collombet, J.M., Carrier, H., Flocard, F., Quard, S., Mousson, B., and Godinot, C., Decreased expression of ubiquinol-cytochrome c reductase subunits in patients exhibiting mitochondrial myopathy with progressive exercise intolerance, Neuromuscular Disord., 3 (1993) 599-604.
9. Boyson, S.J., Parkinson's disease and the electron transport chain, Ann. Neurol., 30 (1991) 330-331.
10. Burns, R.S., Chiueh, C.C., Markey, S.P., Ebert, M.H., Jacobowitz, D.M. and Kopin, I.J., A primate model of Parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of substantia nigra by n-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Proc. Natl. Acad. Sci. USA, 80 (1983) 4546-4550.
11. Capaldi, R.A., Structure and function of cytochrome c oxidase, Annu. Rev. Biochem., 59 (1990) 569-596.
12. Chacon, J.A., Chedekel, M.R., Lane, E.J. and Truscott, T.G., Chemically induced Parkinson's disease: intermediates in the oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to the 1-methyl-4-phenylpyridinium ion, Biochem. Biophys. Res. Commun., 144 (1987) 957-964.
13. Chacon, J.A., Chedekel, M.R., Lane, E.J. and Truscott, T.G., Chemically induced Parkinson's disease: intermediates in the oxidation and reduction of the 1-methyl-4-phenyl-2,3-dihydropyridinium ion and its deprotonated form, Biochem. Biophys. Res. Commun., 158 (1989) 63-71.
14. Chan, P., Delanney, L.E., Irwin, I., Langston, W. and DiMonte, D., Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain, J. Neurochem., 57 (1991) 348-351.
15. +) but not 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) serves a methyl donor for dopamine: a possible mechanism of action, J. Geriatr. Psychiatr. Neurol., 5 (1992) 114-118.
16. Chiba, K., Trevor, A. and Castagnoli, N., Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase, Biochem. Biophys. Res. Commun., 120 (1984) 574-578.
17. +, a metabolite of MPTP, by brain synaptosomes, Biochem. Biophys. Res. Commun., 128 (1985) 1228-1232.
18. Clark, J.B. and Nicklas, W.J., The metabolism of rat brain mitochondria, J. Biol. Chem., 245 (1970) 4724-4731.
19. Cleeter, M.W.J., Cooper, J.M. and Schapira, A.H.V., Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement, J. Neurochem., 58 (1992) 786-789.
20. Davis, G.C., William, A.C., Markey, S.P., Ebert, M.H., Caine, E.D., Reichert, C.M. and Kopin, I.J., Chronic Parkinsonism secondary to intravenous injection of meperidine analogues, Psychiatry Res., 1 (1979) 249-254.
21. +) cause ATP depletion in isolated hepatocytes, Biochem. Biophys. Res. Commun., 137 (1986) 310-315.
22. +, Arch. Biochem. Biophys., 294 (1992) 539-543.
23. Fuller, R.W. and Hemrick Luecke, S.K., Influence of selective, reversible inhibitors of monoamine oxidase on the prolonged depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice, Life Sci., 37 (1985) 1089-1096.
24. Gupta, M., Gupta, B.K., Thomas, R., Bruemmer, V., Sladek, J.R. and Felten, D.L., Aged mice are more sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment than young adults, Neurosci. Lett., 70 (1986) 326-331.
25. + induces NADP dependent superoxide formation and enhances NADH dependent lipid peroxidation in bovine heart submitochondrial particles, Biochem. Biophys. Res. Commun., 170 (1990) 1049-1055.
26. +) to rats, Neurosci. Lett., 59 (1985) 135-140.
27. Hood, D.A., Balaban, A., Connor, M.K., Craig, E.E., Nishio, M.L., Rezvani, M. and Takahashi, M., Mitochondrial biogenesis in striated muscle. Can. J. Appl. Physiol., 19 (1994) 12-48.
28. + in the substantia nigra: a key to neurotoxicity?, Life Sci., 36 (1985) 207-212.
29. Jarvis, M.F. and Wagner, G.C., Age-dependent effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), Neuropharmacology, 24 (1985) 581-583.
30. Javitch, J.A., D'Amato, R.J., Strittmatter, S.M. and Snyder, S.H., Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity, Proc. Natl. Acad. Sci. USA, 82 (1985) 2173-2177.
31. Jenner, P., Rupniak, N.M.J., Rose, S., Kelly, E., Kilpatrick, G., Lees, A. and Marsden, C.D., 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in the common marmoset, Neurosci. Lett., 50 (1984) 85-90.
32. +) induces oxidative stress. Life Sci., 38 (1986) 743-749.
33. +) within catecholaminergic neurons, Neurotoxicology, 12 (1991) 285-302.
34. Langston, J.W., Ballard, P., Tetrud, J.W. and Irwin, I., Chronic Parkinsonism in humans due to a product of merperidine-analog synthesis, Science, 219 (1983) 979-980.
35. Leakey, J.E.A., Cunny, H.C., Bazare, J., Jr., Webb, P.J., Feuers, R.J., Duffy, P.H. and Hart, R.W., Effects of aging and caloric restriction on hepatic drug metabolizing enzymes in the Fischer 344 rat. I: The cytochrome P-450 dependent monooxygenase system, Mech. Ageing Dev., 48 (1989) 145-155.
36. Linnane, A.W., Marzuki, S., Ozawa, T. and Tanaka, M., Mitochondrial DNA mutations as an important contributor to aging and degenerative diseases, Lancet, i (1989) 642-645.
37. Mitchell, I.J., Cross, A.J., Sambrook, M.A. and Crossman, A.R., Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus, Neurosci. Lett., 61 (1985) 195-200.
38. Mizuno, Y., Saitoh, T. and Sone, N., Inhibition of mitochondrial NADH-ubiquinone oxidoreductase activity by 1-methyl-4-phenylpyridium ion, Biochem. Biophys. Res. Commun., 143 (1987) 294-299.
39. Mizuno, Y., Sone, N. and Saitoh, T., Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridium ion on activities of the enzymes in the electron transport system in mouse brain, J. Neurochem., 48 (1987) 1787-1793.
40. Nicklas, W.J., Vyas, I. and Heikkila, R.E., Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, Life Sci., 36 (1985) 2503-2508.
41. + and mitochondrial function. Life Sci., 40 (1987) 721-729.
42. Ozawa, T., Mitochondrial DNA mutations associated with age, Aging Clin. Exp. Res., 5 (1993) 155-158.
43. Poirier, J. and Barbeau, A., A catalyst function for MPTP in superoxide formation, Biochem. Biophys. Res. Commun., 131 (1985) 1284-1289.
44. Ragan, C.I., Wilson, M.T., Darley-Usmar, M. and Lowe, P.N., Subfractionation of mitochondria, and isolation of the protein of oxidative phosphorylation, In: V.M. Darley-Usmar, D. Rickwood and M.T. Wilson (Eds.), Mitochondria: a Practical Approach, IRL Press, London, 1987, pp. 79-112.
45. Ramsay, R.R. and Singer, T.P., Energy-dependent uptake of N-methyl-4-phenylpyridinium, the metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, by mitochondria, J. Biol. Chem., 261 (1986) 7585-7587.
46. +, Biochem. Biophys. Res. Commun., 134 (1986) 743-748.
47. Ramsay, R.R., Dadgar, J., Trevor, A. and Singer, T.P., Energy-driven uptake of N-methyl-4-phenylpyridine by brain mitochondria mediates the neurotoxicity of MPTP, Life Sci., 39 (1986) 581-588.
48. +, the neurotoxic bioactivation product of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, is near the Q-binding site of NADH dehydrogenase, Arch. Biochem. Biophys., 259 (1987) 645-649.
49. Ricaurte, G.A., Irwin, I., Forno, L.S., DeLanney, L.E. and Langston, J.W., Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra, Brain Research, 403 (1987) 43-51.
50. Salach, J.I., Singer, T.P., Castgnoli, N., Jr. and Trevor, A., Oxidation of neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by monoamine oxidases A and B and suicide inactivation of the enzymes by MPTP, Biochem. Biophys. Res. Commun., 125 (1984) 831-835.
51. Schapira, A.H.V., Mann, V.M., Cooper, J.M., Dexter, D., Daniel, S.E., Jenner, P., Clark, J.B. and Marsden, C.D., Anatomic and disease specificity of NADH CoQ reductase (complex I) deficiency in Parkinson's disease, J. Neurochem., 55 (1990) 2142-2145.
52. Sershen, H., Mason, M.F., Hashim, A. and Lajtha, A., Effect of n-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on age-related changes in dopamine turnover and transporter function in the mouse striatum, Eur. J. Pharmacol. 113 (1985) 135-136.
53. +): Reductive activation by NADPH cytochrome P-450 reductase, Biochem. Biophys. Res. Commun., 135 (1986) 583-588.
54. Torri, K., Sugiyama, S., Takagi, K., Satake, T. and Takayuki, O., Age-related decrease in respiratory muscle mitochondrial function in rats, Am. J. Resp. Cell. Mol. Biol., 6 (1992) 88-92.
55. Turrens, J.F., Alexandre, A. and Lehninger, A.L., Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria, Arch. Biochem. Biophys., 237 (1985) 408-414.
56. Vyas, I., Heikkila, R.E. and Nicklas, W.J., Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridinium, J. Neurochem., 46 (1986) 1501-1507.
57. Wagner, G.C. and Jarvis, M.F., Age-dependent effects of MPTP. In: S. Markey, N. Castagnoli, A. Trevor and I. Kopin (Eds.), MPTP -A Neurotoxin Producing a Parkinsonian Syndrome, Academic Press, New York, 1986, pp. 461-465.
58. Wallace, D.C., Diseases of the mitochondrial DNA, Annu. Rev. Biochem., 61 (1922) 1175-1212.
59. Weissman, J., Trevor, A., Chiba, K., Peterson, L.A., Caldera, P. and Castagnoli, N., Jr., Metabolism of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by liver homogenate fractions, J. Med. Chem., 28 (1985) 997-1001.
60. Wilson, D.F., Stubbs, M., Veech, R.I., Erecinska, M. and Krebs, H.A., Equilibrium relation between the oxidation-reduction reactions and the adenosine triphosphate synthesis in suspensions of isolated liver cells, Biochem. J., 140 (1974) 57-64.